The dysfunction of the TFEB/TFE3‐mediated autophagy‐lysosomal pathway (ALP) plays a critical role in the pathogenesis of AD and high‐fat diet (HFD)‐induced nonalcoholic fatty liver disease (NAFLD) [45]. Here, TFE3 is linked to metabolic dysfunction-associated steatotic liver disease.